SCHEMBL14425657

SCHEMBL14425657

O=S(=O)(Nc1cccc(CO)c1)c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.72
IKBKB O14920 1/20 0.70
ALDH1A1 P00352 4/20 0.61
IL1RN P18510 1/20 0.59
KEAP1 Q14145 1/20 0.59
ERAP1 Q9NZ08 1/20 0.59
PTGES O14684 1/20 0.56
MEN1 O00255 1/20 0.56
PKM P14618 1/20 0.56
KMT2A Q03164 1/20 0.56
GAA P10253 2/20 0.55
HPGD P15428 1/20 0.55
PHGDH O43175 1/20 0.55
LMNA P02545 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
GFER P55789 1/20 0.53
APOBEC3G Q9HC16 1/20 0.53
PGR P06401 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2889311 0.91 IKBKB (0.67) HTR6IKBKBALDH1A1PHGDHPOLB
SCHEMBL4064536 0.90 HTR6 (0.68) HTR6IKBKBALDH1A1IL1RNKEAP1
SCHEMBL6973491 0.86 IKBKB (0.69) HTR6IKBKBALDH1A1MEN1KMT2A
SCHEMBL2889176 0.86 IKBKB (0.69) HTR6IKBKBALDH1A1PKMPHGDH
SCHEMBL246188 0.84 HTR6 (0.72) HTR6IKBKBALDH1A1IL1RNKEAP1
SCHEMBL27482732 0.84 HTR6 (0.72) HTR6IKBKBALDH1A1IL1RNKEAP1
SCHEMBL1690514 0.84 HTR6 (0.72) HTR6ALDH1A1IL1RNKEAP1ERAP1
SCHEMBL13028510 0.83 IKBKB (0.64) HTR6IKBKBALDH1A1MEN1KMT2A
SCHEMBL13028493 0.83 IKBKB (0.64) HTR6IKBKBALDH1A1PHGDHSMN1; SMN2
SCHEMBL2891992 0.83 IKBKB (0.68) HTR6IKBKBALDH1A1MEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39850-E1 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents METHYLGENE, INC. (CA) 2007-09-18 US disclosed